OUR WORK
Our work spans strategy through execution, supporting healthcare startups as they move from early positioning to launch and early growth. We partner closely with founders, CEOs, CMOs, and commercial leaders to bring clarity to complex innovation and turn it into market-ready momentum.
The case studies that follow show how we translate complex innovation into clear market narratives that support early growth, enterprise adoption, or strategic exits.
NOVEL DIAGNOSTIC PLATFORM
Category: Diagnostics, Health Technology
Stage: Pre-Series A (Angel/Seed funded), acquisition-oriented
​
Challenge: The Company ("K") was building a novel diagnostics platform without an established category or shared market language. From the start, the company needed a brand and narrative that could support early traction while also standing up to future strategic and acquisition conversations.
​
Action:
-
Built Company's brand, positioning, and messaging from the ground up
-
Defined a clear market narrative for the new diagnostics platform
-
Translated complex science into credible, accessible stories for external audiences
-
Established a consistent digital and social presence to support thought leadership, fundraising, and strategic visibility
​
Impact: The Company emerged with a cohesive market identity that supported growth, strategic engagement, and long-term value creation. As the narrative took hold, the company’s LinkedIn presence grew from fewer than 500 followers to nearly 1,500, reflecting increased visibility and resonance across the healthcare ecosystem. The big win was an oversubscribed Series A funding round.
​
POPULATION HEALTH PREDICTIVE SCREENING
Category: Diagnostics, Health Technology
Stage: Growth
​
​Challenge: The Company ("J") was advancing a population health solution focused on early risk identification and predictive insight. The challenge was translating complex data science and clinical insight into a compelling narrative for health systems, payers, and enterprise partners operating in value-based care environments.
​
What we did:
-
Clarified positioning at the intersection of population health and predictive diagnostics
-
Developed messaging that connected clinical insight to cost, quality, and outcomes
-
Shaped market-facing narratives for enterprise buyers and strategic partners
-
Supported business development storytelling and market education efforts
Impact:"J" strengthened its commercial narrative and market presence, enabling clearer, more effective conversations with health systems, payers, and partners focused on value-based care and population-level decision-making.
INNOVATION FOR INSULIN DELIVERY
Category: Medical Device, Diabetes Technology
Stage: Early-stage startup with acquisition intent
​
​Challenge: The Company ("C") was developing a novel medical device with a clearly defined end goal: acquisition. From the outset, the company needed a name, brand, and positioning that could withstand scrutiny from strategic buyers while clearly communicating differentiation, clinical relevance, and future value.
What we did:
-
Supported brand development with acquisition as the guiding objective
-
Helped shape naming, positioning, and messaging aligned to strategic buyer expectations
-
Built a market narrative balancing technical rigor with commercial clarity
-
Ensured consistency across brand, product story, and external communications
The impact: "C" developed a clear, credible market identity that supported strategic positioning and long-term value creation, ultimately contributing to its acquisition by Tandem Diabetes Care.